SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001571049-16-018407
Filing Date
2016-09-23
Accepted
2016-09-23 16:05:47
Documents
5
Period of Report
2016-11-07
Effectiveness Date
2016-09-23

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT t1602251-def14a.htm DEF 14A 492164
2 GRAPHIC lg_phibrocorp-cmyk.jpg GRAPHIC 177114
3 GRAPHIC sg_thomas-dagger.jpg GRAPHIC 19312
4 GRAPHIC t1602251_pc-pg01.jpg GRAPHIC 304315
5 GRAPHIC t1602251_pc-pg02.jpg GRAPHIC 203356
  Complete submission text file 0001571049-16-018407.txt   1436781
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-36410 | Film No.: 161899886
SIC: 2834 Pharmaceutical Preparations